Summary
Updated Aug 31, 2026
Andrew R. Allen files SEC Form 4 reports at Cullinan Therapeutics, Inc. (CGEM). 2 SEC Form 4 filings on record going back to 2025, most recently on 18 June 2026.
Trading Pattern
InsiderAlpha's records for Andrew R. Allen go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew R. Allen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lynx1 Capital Management LP - $13.32M of CGEM open-market activity in the last 12 months
- Jennifer Michaelson - $1.44M of CGEM open-market activity in the last 12 months
- Nadim Ahmed - $518K of CGEM open-market activity in the last 12 months
- Jeffrey Alan Jones - $179K of CGEM open-market activity in the last 12 months
- Jacquelyn L. Sumer - $137K of CGEM open-market activity in the last 12 months
- Mary Kay Fenton - $60K of CGEM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Andrew R. Allen?
Andrew R. Allen is a corporate insider of Cullinan Therapeutics, Inc. (CGEM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew R. Allen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Andrew R. Allen's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Andrew R. Allen and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial